MPGOX
Price
$8.81
Change
-$0.00 (-0.00%)
Updated
Jun 20 closing price
Net Assets
105.97M
TFBVX
Price
$10.80
Change
-$0.00 (-0.00%)
Updated
Jun 20 closing price
Net Assets
1.29B
Interact to see
Advertisement

MPGOX vs TFBVX

Header iconMPGOX vs TFBVX Comparison
Open Charts MPGOX vs TFBVXBanner chart's image
MFS GA Municipal Bond R6
Price$8.81
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets105.97M
T. Rowe Price Virginia Tax Free Bond I
Price$10.80
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets1.29B
MPGOX vs TFBVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MPGOX vs. TFBVX commentary
Jun 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MPGOX is a Hold and TFBVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TFBVX has more cash in the bank: 1.3B vs. MPGOX (106M). TFBVX (3.48) and MPGOX (3.39) have matching dividends . MPGOX was incepted earlier than TFBVX: MPGOX (8 years) vs TFBVX (8 years). MPGOX (0.68) is less costly to investors than TFBVX (0.42). MPGOX (20.00) and TFBVX (19.10) have comparable annual turnover. MPGOX has a lower initial minimum investment than TFBVX: MPGOX (0) vs TFBVX (500000). MPGOX annual gain was more profitable for investors over the last year : -0.50 vs. TFBVX (-0.81). MPGOX return over 5 years is better than : 1.97 vs. TFBVX (0.96).
MPGOXTFBVXMPGOX / TFBVX
Total Expense Ratio0.600.42143%
Annual Report Gross Expense Ratio0.680.42162%
Fund Existence8 years8 years-
Gain YTD-2.022-2.36086%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets106M1.3B8%
Annual Yield % from dividends3.393.4898%
Returns for 1 year-0.50-0.8162%
Returns for 3 years7.778.4492%
Returns for 5 years1.970.96206%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VGIFX85.110.10
+0.12%
JPMorgan US Value R5
SCAVX13.65N/A
N/A
AB Small Cap Value A
MVISX43.19N/A
N/A
Patient Opportunity IS
FISGX39.46-0.12
-0.30%
Nuveen Small/Mid Cap Growth Opp I
RYWVX69.86-1.66
-2.32%
Rydex Emerging Markets 2X Strategy H